AAAAAA

   
Results: 1-10 |
Results: 10
Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma
Authors: Enschede, SH Shahidi, H Venugopal, P Riley, MB Huang, RW Jajeh, A Preisler, HD Gregory, SA
Citation: Sh. Enschede et al., Effectiveness of interferon-alfa and mid-cycle chemotherapy added to an anthracycline-based regimen in the treatment of aggressive non-Hodgkin's lymphoma, LEUK LYMPH, 40(3-4), 2001, pp. 325-334
Factors affecting performance on the American Board of Surgery in-trainingexamination
Authors: Godellas, CV Huang, RW
Citation: Cv. Godellas et Rw. Huang, Factors affecting performance on the American Board of Surgery in-trainingexamination, AM J SURG, 181(4), 2001, pp. 294-296
Suppression of telomerase activity and cytokine messenger RNA levels in acute myelogenous leukemia cells in vivo in patients by amifostine and interleukin 4
Authors: Preisler, HD Li, B Yang, J Huang, RW Devemy, E Venugopal, P Tao, M Chopra, H Gregory, SA Adler, S Sivaraman, S Toofanfard, P Jajeh, A Galvez, A Robin, E
Citation: Hd. Preisler et al., Suppression of telomerase activity and cytokine messenger RNA levels in acute myelogenous leukemia cells in vivo in patients by amifostine and interleukin 4, CLIN CANC R, 6(3), 2000, pp. 807-812
Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: A new role for TNF alpha?
Authors: Sivaraman, S Deshpande, CG Ranganathan, R Huang, X Jajeh, A O'Brien, T Huang, RW Gregory, SA Venugopal, P Preisler, HD
Citation: S. Sivaraman et al., Tumor necrosis factor modulates CD 20 expression on cells from chronic lymphocytic leukemia: A new role for TNF alpha?, MICROSC RES, 50(3), 2000, pp. 251-257
SCF, IL-1 beta, IL-1ra and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML patients
Authors: Tao, M Li, BR Nayini, J Andrews, CB Huang, RW Devemy, E Song, SW Venugopal, P Preisler, HD
Citation: M. Tao et al., SCF, IL-1 beta, IL-1ra and GM-CSF in the bone marrow and serum of normal individuals and of AML and CML patients, CYTOKINE, 12(6), 2000, pp. 699-707
Telomerase activity in preleukemia and acute myelogenous leukemia
Authors: Li, BR Yang, J Andrews, C Chen, YX Toofanfard, P Huang, RW Horvath, E Chopra, H Raza, A Preisler, HD
Citation: Br. Li et al., Telomerase activity in preleukemia and acute myelogenous leukemia, LEUK LYMPH, 36(5-6), 2000, pp. 579-587
Factors affecting improvement on the American Board of Surgery In-TrainingExam (ABSITE)
Authors: Godellas, CV Hauge, LS Huang, RW
Citation: Cv. Godellas et al., Factors affecting improvement on the American Board of Surgery In-TrainingExam (ABSITE), J SURG RES, 91(1), 2000, pp. 1-4
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone
Authors: Raza, A Qawi, H Lisak, L Andric, T Dar, S Andrews, C Venugopal, P Gezer, S Gregory, S Loew, J Robin, E Rifkin, S Hsu, WT Huang, RW
Citation: A. Raza et al., Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone, BLOOD, 95(5), 2000, pp. 1580-1587
Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis
Authors: Dar, S Mundle, S Andric, T Qawi, H Shetty, V Reza, S Mativi, BY Allampallam, K Ali, A Venugopal, P Gezer, S Broady-Robinson, L Cartlidge, J Showel, M Hussaini, S Ragasa, D Ali, I Chaudhry, A Waggoner, S Lisak, L Huang, RW Raza, A
Citation: S. Dar et al., Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis, EUR J HAEMA, 62(2), 1999, pp. 90-94
Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes
Authors: Allampallam, K Shetty, V Hussaini, S Mazzoran, L Zorat, F Huang, RW Raza, A
Citation: K. Allampallam et al., Measurement of mRNA expression for a variety of cytokines and its receptors in bone marrows of patients with myelodysplastic syndromes, ANTICANC R, 19(6B), 1999, pp. 5323-5328
Risultati: 1-10 |